John McCamant

John McCamant joined the Medical Technology Stock Letter as associate editor in 1987 and was named editor of this leading investment newsletter in August 2000. He has spent over 25 years on the front lines of biotechnology investing. As an equities analyst for the American Healthcare Fund, Mr. McCamant uncovered investment opportunities and guided investment strategy. At Burrill & Company, a San Francisco-based private merchant bank, he was a lead in raising $75 million for a venture capital fund.


Contact Information

John T. McCamant
Editor, Medical Technology Stock Letter
PO Box 40460
Berkeley, CA 94704
E-mail: mtsl@bioinvest.com
Web site: www.bioinvest.com

Content from John McCamant